There is also a possible mechanism of upregulation of MCL-1 expression and downregulation of BCL-2 and BAX expression in some AML cells due to activation of NF-KB pathway and ERK pathway by KRAS mutations (36). The gene discussed is BCL2; the disease is acute myeloid leukemia.